BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) | Financial Trends

Health

Does BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) appear drenched?

Ash Khandelwal -

Health

A look at BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) from another angle

Aaron Lyons -

Health

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX): Announced Positive Phase-II Trial Results For BCX4161

Neha Rathod -

Health

Dyax Corp. (NASDAQ:DYAX): Gains 27% Following Biocryst’s OPuS-1 Success

Rebecca Harrison -

Health

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) gets fund from NIAID

Aaron Lyons -

Health

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)’s Managing Director Fred E. Cohen got elected

Neha Rathod -

Health

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) – Fred Cohen Nominated to BioCryst’s Board’s...

Brandon Manns -